Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Lack of adjuvant radiotherapy may increase risk of retropharyngeal node recurrence in patients with squamous cell carcinoma of the head and neck after transoral robotic surgery.

Mourad WF, Blakaj DM, Kabarriti R, Young R, Shourbaji RA, Glanzman J, Patel S, Yaparpalvi R, Kalnicki S, Garg MK.

Case Rep Oncol Med. 2013;2013:727904. doi: 10.1155/2013/727904. Epub 2013 Jun 13.

2.
3.

Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.

Eisbruch A, Marsh LH, Dawson LA, Bradford CR, Teknos TN, Chepeha DB, Worden FP, Urba S, Lin A, Schipper MJ, Wolf GT.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):28-42.

PMID:
15093896
4.

Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.

Tan A, Adelstein DJ, Rybicki LA, Saxton JP, Esclamado RM, Wood BG, Lorenz RR, Strome M, Carroll MA.

Arch Otolaryngol Head Neck Surg. 2007 May;133(5):435-40.

PMID:
17515501
5.

Two-Year Survival Analysis of 50 Consecutive Head and Neck Cancer Patients Treated with Transoral Robotic Surgery in a Single European Centre.

Lörincz BB, Möckelmann N, Busch CJ, Münscher A, Sehner S, Dalchow CV, Knecht R.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1028-33. doi: 10.1245/s10434-015-4581-5. Epub 2015 May 13.

PMID:
25968617
6.

Transoral robotic surgery for supraglottic squamous cell carcinoma.

Olsen SM, Moore EJ, Koch CA, Price DL, Kasperbauer JL, Olsen KD.

Am J Otolaryngol. 2012 Jul-Aug;33(4):379-84. doi: 10.1016/j.amjoto.2011.10.007. Epub 2011 Nov 30.

PMID:
22133967
7.

The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.

Yao M, Smith RB, Graham MM, Hoffman HT, Tan H, Funk GF, Graham SM, Chang K, Dornfeld KJ, Menda Y, Buatti JM.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):991-9. Epub 2005 Aug 15.

PMID:
16099601
8.

Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer.

Lavertu P, Adelstein DJ, Saxton JP, Secic M, Wanamaker JR, Eliachar I, Wood BG, Strome M.

Head Neck. 1997 Oct;19(7):559-66.

PMID:
9323143
9.

Transoral robotic surgery (TORS) for tongue base tumours.

Mercante G, Ruscito P, Pellini R, Cristalli G, Spriano G.

Acta Otorhinolaryngol Ital. 2013 Aug;33(4):230-5.

10.

Long-term follow-up after transoral laser microsurgery and adjuvant radiotherapy for advanced recurrent squamous cell carcinoma of the head and neck.

Christiansen H, Hermann RM, Martin A, Florez R, Kahler E, Nitsche M, Hille A, Steiner W, Hess CF, Pradier O.

Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1067-74. Epub 2006 Jun 5.

PMID:
16750331
11.

Transoral robotic resection and reconstruction for head and neck cancer.

Genden EM, Kotz T, Tong CC, Smith C, Sikora AG, Teng MS, Packer SH, Lawson WL, Kao J.

Laryngoscope. 2011 Aug;121(8):1668-74. doi: 10.1002/lary.21845.

PMID:
21792953
12.

Transoral resection for squamous cell carcinoma of the base of the tongue.

Henstrom DK, Moore EJ, Olsen KD, Kasperbauer JL, McGree ME.

Arch Otolaryngol Head Neck Surg. 2009 Dec;135(12):1231-8. doi: 10.1001/archoto.2009.177.

PMID:
20026821
13.

Squamous cell carcinoma from an unknown head and neck primary site: a "selective treatment" approach.

Patel RS, Clark J, Wyten R, Gao K, O'Brien CJ.

Arch Otolaryngol Head Neck Surg. 2007 Dec;133(12):1282-7.

PMID:
18086973
14.

A new paradigm for the diagnosis and management of unknown primary tumors of the head and neck: a role for transoral robotic surgery.

Mehta V, Johnson P, Tassler A, Kim S, Ferris RL, Nance M, Johnson JT, Duvvuri U.

Laryngoscope. 2013 Jan;123(1):146-51. doi: 10.1002/lary.23562. Epub 2012 Nov 14.

PMID:
23154813
15.

Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer.

Dawson LA, Anzai Y, Marsh L, Martel MK, Paulino A, Ship JA, Eisbruch A.

Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1117-26.

PMID:
10725621
16.

[Squamous-cell carcinoma of the tongue: treatment results and prognosis].

Zwetyenga N, Majoufre-Lefebvre C, Siberchicot F, Demeaux H, Pinsolle J.

Rev Stomatol Chir Maxillofac. 2003 Feb;104(1):10-7. French.

PMID:
12644785
17.

Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.

Kim SY, Kim JS, Yi JS, Lee JH, Choi SH, Nam SY, Cho KJ, Lee SW, Kim SB, Roh JL.

Ann Surg Oncol. 2011 Sep;18(9):2579-84. doi: 10.1245/s10434-011-1655-x. Epub 2011 Mar 16.

PMID:
21409485
18.

TORS for head and neck squamous cell carcinoma (HNSCC): the Hamburg experience.

Lörincz BB, Knecht R.

B-ENT. 2015;Suppl 24:33-6.

PMID:
26891529
19.

Treatment of the N0 neck during salvage surgery after radiotherapy of head and neck squamous cell carcinoma.

Temam S, Koka V, Mamelle G, Julieron M, Carmantrant R, Marandas P, Janot F, Bourhis J, Luboinski B.

Head Neck. 2005 Aug;27(8):653-8.

PMID:
16035097
20.
Items per page

Supplemental Content

Write to the Help Desk